By Drug Target Review2024-05-07T15:00:32
Scientists have discovered that each rheumatoid arthritis patient possesses a unique and diverse set of ACPAs.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-18T14:47:08Z
2023-09-27T13:56:39
Sponsored by Euretos
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2023-03-23T14:46:21
Sponsored by Bio-Techne
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2023-05-18T10:39:07
Sponsored by BPS Bioscience
Site powered by Webvision Cloud